Topics

As Opponents Predicted, ‘Right To Try’ Law Fizzles Without Drugmakers’ Buy-In

08:54 EDT 13 Sep 2019 | Kaiser Health News

Drugmakers prefer to have their products go through the FDA approval process. “At the end of the day, [companies] control their products. It’s their property. You can pass a law saying people can try things, but unless you obligate companies to give something, there’s no right to gain access,” said Arthur Caplan, who heads the division of medical ethics at the NYU School of Medicine.

Original Article: As Opponents Predicted, ‘Right To Try’ Law Fizzles Without Drugmakers’ Buy-In

NEXT ARTICLE

More From BioPortfolio on "As Opponents Predicted, ‘Right To Try’ Law Fizzles Without Drugmakers’ Buy-In"

Quick Search

Relevant Topic

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...